Longboard Pharmaceuticals(LBPH) - 2023 Q4 - Annual Results

Exhibit 99.1 Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates LA JOLLA, Calif., March 12, 2024 – Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today provided a corporate update and reported full year 2023 financial results. "I am extremely proud of what our team has accomplished starting with the immense effort that went into the PACIF ...

Longboard Pharmaceuticals(LBPH) - 2023 Q4 - Annual Results - Reportify